Continuous Connected Patient Care (CCPC), a Pilot Testing a Novel Device for Continuous Vitals Monitoring - Older Adults Department PHC

ConditionAging
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age65+
SponsorMedtronic - MITG

About this trial

To confirm feasibility and accessibility of the CCPC Platform (Oxymotion, Bridge Health Solutions medication adherence software, CloudDX home kit) in two different environments - 1) hospital (Acute Care for Elderly Unit) and 2) at-home .

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Inpatients on the Acute care of the Elderly ward.

Disqualifiers

Lack of capacity to consent to the study including moderate-severe dementia or delirium

Unable to use (or does not have a caregiver who can help put on) study monitoring device at home

Unable to complete (or does not have a caregiver who can help complete) study questionnaires by electronic (mobile, tablet, or computer), paper, nor phone

Patient with known allergic reactions to any part material of the device

Trial population

The Acute Care for Elderly Unit at SPH for 40 inpatients over the age of 65.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Collect patient and clinicians' feedback about the CCPC Platform

This will be completed via an assessment of the quantitative data on how long and how often patients use this monitoring and what were the reasons that patients took the monitors on and off.

Time frame
From enrollment to the end of follow up at 10 days
2

Collect patient and clinicians' feedback about the CCPC Platform

This will be completed via an assessment of the Usability Questionnaire.

Time frame
From enrollment to the end of follow up at 10 days
3

Collect patient and clinicians' feedback about the CCPC Platform

This will be completed by an evaluation for potential harm, e.g. anxiety questionnaire and any patient-reported adverse events.

Time frame
From enrollment to the end of follow up at 10 days
4

Confirm the technical goals of the CCPC platform are met.

This will be completed by ensuring clinician workflow is met, via feedback sessions (e.g. conversations, questionnaires).

Time frame
From enrollment to the end of follow up at 10 days

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Medtronic - MITG

Lead sponsor

Excelar

Collaborator

Cloud DX Inc.

Collaborator

Bridge Health Solutions

Collaborator

Providence Healthcare

Collaborator